Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 39,579 | 36,182 | 36,188 | 26,046 | 20,050 |
| Operating Income | -38,044 | -36,182 | -36,188 | -26,046 | -20,050 |
| Other Income | 182 | -126 | 409 | 248 | 193 |
| Pre-tax Income | -37,862 | -36,308 | -35,779 | -25,798 | -19,857 |
| Net Income Continuous | -37,862 | -36,308 | -35,779 | -25,798 | -19,857 |
| Net Income | $-37,862 | $-36,308 | $-35,779 | $-25,798 | $-19,857 |
| EPS Basic Total Ops | -0.99 | -0.96 | -0.95 | -0.70 | -0.68 |
| EPS Basic Continuous Ops | -1.00 | -0.96 | -0.95 | -0.70 | -0.68 |
| EPS Diluted Total Ops | -0.99 | -0.96 | -0.95 | -0.70 | -0.68 |
| EPS Diluted Continuous Ops | -1.00 | -0.96 | -0.95 | -0.70 | -0.68 |
| EBITDA(a) | $-39,360 | $-35,976 | $-35,999 | $-25,870 | $-19,899 |